AzTrials
AzTrials

Low Back PainNCT03169140

Effect of at Home Pain Management Products on Acute Low Back Pain, Disability, and Range of Motion

A study testing TheraBand Kinesiology Tape, Biofreeze and Advice in people with Low Back Pain and Acute Pain, run by Sport and Spine Rehab Clinical Research Foundation at 1 site in United States.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

The purpose of this study is to compare the effect of a combination of separate therapies of Biofreeze® and TheraBand Kinesiology Tape to advice on acute pain, disability and fear avoidance among low back patients over a 1-week period of time. Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Low Back Pain, Acute Pain
What is being tested?
TheraBand Kinesiology Tape, Biofreeze and Advice
Could I receive a placebo?
No, everyone receives an active treatment
How many people
120 participants
Where
1 siteUnited States
Study dates
14 Feb 2017to 31 Jul 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • low back pain for less than 2 weeks and 18 years of age or older

Who cannot join

  • pregnancy, cancer, or a corticosteroid injection within the past 2 weeks and a history of low back surgery

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Sport and Spine Rehab

    Rockville, Maryland, 20852

Other trials in United States

About this study

Official title: Effect of Biofreeze®, TheraBand® Kinesiology Tape, or the Combination of Products on Acute Low Back Pain, Disability, and Range of Motion

The purpose of this study is to compare the effect of a combination of separate therapies of Biofreeze® and TheraBand Kinesiology Tape to advice on acute pain, disability and fear avoidance among low back patients over a 1-week period of time.

Read the detailed description

A convenience sample of 120 acute low back pain patients will be recruited from Sport and Spine Rehab at their initial appointment. Exclusionary criteria will include pregnancy, cancer, or a corticosteroid injection within the past 2 weeks. Additionally, anyone who has a history of low back surgery will be excluded. Patients will be recruited following their initial examination if they meet the inclusion criteria of reporting low back pain for less than 2 weeks and be >18 years of age. Patients will complete the informed consent, demographics information questionnaire, Numeric Pain Rating Scale (NPRS), Roland-Morris Low Back Pain and Disability Questionnaire (RMDQ), Fear Avoidance Beliefs Questionnaire (FABQ). Following paper documents their lumbar range of motion and posture will be analyzed using the DorsaVi ViMove device [http://us.dorsavi.com/vimove/] (T1). After completing T1, patients will then be randomized into 1 of 4 at-home pain management groups (n=30 per group), to be followed for one week. Group 1 (Biofreeze® + Tape), Group 2 (Tape Only), Group 3 (Biofreeze Only), and Group 4 (Advice Alone). Treatment at the first office visit will be standardized to include manipulation only; no in-office therapy will be provided to either group at the first visit. Upon returning for their 2nd (T2), and 3rd (T3) office visits, all patients will rate their pain (NPRS). At one week (T4) patients will complete the paper and pencil instruments from the first visit, which assess the subjects' pain on the Numeric Pain Rating Scale (NPRS), low back disability on the Roland-Morris Low Back Pain and Disability Questionnaire (RMDQ), and fear on the Fear Avoidance Beliefs Questionnaire (FABQ). Lumbar range of motion and posture will also be reassessed. In addition,, at home pain management compliance and pain medication will be documented on a daily basis for the entire week.

Being tested
TheraBand Kinesiology Tape, Biofreeze, Advice
Keywords
pain management, topical analgesic, acute low back pain, kinesiology tape
Medical subject headings
Low Back Pain, Acute Pain, Agnosia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • TheraBand Kinesiology TapeDevice

    A 20 cm strip of tape will be applied to each side of the low back directly over the erector spinae muscles at the site of pain. This tape will remain there, and be reapplied when necessary, for one week.

  • BiofreezeDevice

    The topical analgesic will be sprayed directly on top of the erector spinae and site of pain low back directly, from inferior to superior to inferior 4 times a day for one week.

  • AdviceBehavioural

    An at-home pain management care sheet, outlining standard care advice will be followed for at home pain management for one week.

Study groups in NCT03169140
Study groupRoleWhat they receive
Group 1Active comparatorReceive a combination of products (TheraBand Kinesiology Tape and Biofreeze) to use for one week for at home pain management.
Receives: Device: TheraBand Kinesiology Tape; Device: Biofreeze
Group 2Active comparatorReceive TheraBand Kinesiology Tape product to use for one week for at home pain management.
Receives: Device: TheraBand Kinesiology Tape
Group 3Active comparatorReceive a topical product, Biofreeze, to use for one week for at home pain management
Receives: Device: Biofreeze
Group 4Active comparatorReceive advice sheet outlining at home pain management strategies to use for one week.
Receives: Behavioral: Advice

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Numeric Pain Rating Scale (NPRS) over one week

    Measured: Baseline (T1), Day 2 (T2), Day 4 (T3), 1 week (T4)

  2. Change in Roland-Morris Low Back Pain and Disability Questionnaire (RMDQ) over one week

    Measured: Baseline (T1), 1 week (T4)

  3. Change in Fear Avoidance Beliefs Questionnaire (FABQ) over one week

    Measured: Baseline (T1), 1 week (T4)

  4. Change in lumbar range of motion over one week

    Using the DorsaVi sensor technology lumbar flexion, extension, and side bending will be measures

    Measured: Baseline (T1), 1 week (T4)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 May 2017
  2. Study start14 Feb 2017
  3. Primary completion31 Jul 2024
  4. Study completion31 Jul 2024

Why it stopped: Decided not to proceed

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
120 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03169140
Sponsor's protocol ID
Low Back Home Care
Status last verified
Jul 2024
First submitted
16 May 2017
Last updated
2 Aug 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing TheraBand Kinesiology Tape, Biofreeze and Advice in people with Low Back Pain and Acute Pain, run by Sport and Spine Rehab Clinical Research Foundation at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 2 Aug 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: Decided not to proceed). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Numeric Pain Rating Scale (NPRS) over one week (time frame: Baseline (T1), Day 2 (T2), Day 4 (T3), 1 week (T4)). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Aug 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in